<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23383040</PMID><DateCompleted><Year>2013</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Dengue virus enhances thrombomodulin and ICAM-1 expression through the macrophage migration inhibitory factor induction of the MAPK and PI3K signaling pathways.</ArticleTitle><Pagination><StartPage>e55018</StartPage><MedlinePgn>e55018</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e55018</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0055018</ELocationID><Abstract><AbstractText>Dengue virus (DV) infections cause mild dengue fever (DF) or severe life-threatening dengue hemorrhagic fever (DHF). The mechanisms that cause hemorrhage in DV infections remain poorly understood. Thrombomodulin (TM) is a glycoprotein expressed on the surface of vascular endothelial cells that plays an important role in the thrombin-mediated activation of protein C. Prior studies have shown that the serum levels of soluble TM (sTM) and macrophage migration inhibitory factor (MIF) are significantly increased in DHF patients compared to levels in DF patients or normal controls. In this study, we investigated how MIF and sTM concentrations are enhanced in the plasma of DHF patients and the potential effect of MIF on coagulation through its influence on two factors: thrombomodulin (TM) and intercellular adhesion molecule-1 (ICAM-1) in endothelial cells and monocytes. Recombinant human macrophage migration inhibitory factor (rMIF) was used to treat monocytic THP-1 cells and endothelial HMEC-1 cells or primary HUVEC cells. The subsequent expression of TM and ICAM-1 was assessed by immunofluorescent staining and flow cytometry analysis. Additionally, the co-incubation of THP-1 cells with various cell signaling pathway inhibitors was used to determine the pathways through which MIF mediated its effect. The data provided evidence that severe DV infections induce MIF expression, which in turn stimulates monocytes or endothelial cells to express TM and ICAM-1 via the Erk, JNK MAPK and the PI3K signaling pathways, supporting the idea that MIF may play an important role as a regulator of coagulation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Trai-Ming</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Medical Technology, National Cheng Kung University, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Shu-Hsiang</ForeName><Initials>SH</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Kao-Chang</ForeName><Initials>KC</Initials></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Chieh</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Shu-Yun</ForeName><Initials>SY</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Tzuu-Yuan</ForeName><Initials>TY</Initials></Author><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Yong-Ren</ForeName><Initials>YR</Initials></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Rong-Kun</ForeName><Initials>RK</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lien-Cheng</ForeName><Initials>LC</Initials></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Tsai-Feng</ForeName><Initials>TF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008263">Macrophage Migration-Inhibitory Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011486">Protein C</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018180">Thrombomodulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>126547-89-5</RegistryNumber><NameOfSubstance UI="D018799">Intercellular Adhesion Molecule-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018799" MajorTopicYN="N">Intercellular Adhesion Molecule-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="Y">MAP Kinase Signaling System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008263" MajorTopicYN="N">Macrophage Migration-Inhibitory Factors</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011486" MajorTopicYN="N">Protein C</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019595" MajorTopicYN="N">Severe Dengue</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018180" MajorTopicYN="N">Thrombomodulin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23383040</ArticleId><ArticleId IdType="pmc">PMC3557271</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0055018</ArticleId><ArticleId IdType="pii">PONE-D-12-26106</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gubler DJ (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88892</ArticleId><ArticleId IdType="pubmed">9665979</ArticleId></ArticleIdList></Reference><Reference><Citation>Mairuhu AT, Mac Gillavry MR, Setiati TE, Soemantri A, ten Cate H, et al. (2003) Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect Dis 3: 33&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">12505032</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YH, Liu CC, Wang ST, Lei HY, Liu HL, et al. (2001) Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol 63: 247&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170065</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gorp EC, Minnema MC, Suharti C, Mairuhu AT, Brandjes DP, et al. (2001) Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever. Br J Haematol 113: 94&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">11328287</ArticleId></ArticleIdList></Reference><Reference><Citation>Suharti C, van Gorp EC, Setiati TE, Dolmans WM, Djokomoeljanto RJ, et al. (2002) The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb Haemost 87: 42&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">11858187</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Gorp EC, Setiati TE, Mairuhu AT, Suharti C, Cate Ht H, et al. (2002) Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever. Journal of medical virology 67: 549&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">12116003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, et al. (2002) Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 35: 277&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">12115093</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Wouwer M, Conway EM (2004) Novel functions of thrombomodulin in inflammation. Critical care medicine 32: S254&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">15118527</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiler H, Isermann BH (2003) Thrombomodulin. Journal of thrombosis and haemostasis : JTH 1: 1515&#x2013;1524.</Citation><ArticleIdList><ArticleId IdType="pubmed">12871287</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, et al. (2006) Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. The American journal of tropical medicine and hygiene 74: 142&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">16407359</ArticleId></ArticleIdList></Reference><Reference><Citation>Butthep P, Chunhakan S, Tangnararatchakit K, Yoksan S, Pattanapanyasat K, et al. (2006) Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome. The Pediatric infectious disease journal 25: 894&#x2013;897.</Citation><ArticleIdList><ArticleId IdType="pubmed">17006283</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M (1998) Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 161: 6338&#x2013;6346.</Citation><ArticleIdList><ArticleId IdType="pubmed">9834124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunyaratvej A, Butthep P, Yoksan S, Bhamarapravati N (1997) Dengue viruses induce cell proliferation and morphological changes of endothelial cells. Southeast Asian J Trop Med Public Health 28 Suppl 332&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">9640597</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessie K, Fong MY, Devi S, Lam SK, Wong KT (2004) Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 189: 1411&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pubmed">15073678</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, et al. (2000) Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. The American journal of tropical medicine and hygiene 63: 71&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">11357999</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YH, Lei HY, Liu HS, Lin YS, Chen SH, et al. (2003) Tissue plasminogen activator induced by dengue virus infection of human endothelial cells. J Med Virol 70: 610&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pubmed">12794725</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamurti C, Peat RA, Cutting MA, Rothwell SW (2002) Platelet adhesion to dengue-2 virus-infected endothelial cells. The American journal of tropical medicine and hygiene 66: 435&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">12164302</ArticleId></ArticleIdList></Reference><Reference><Citation>Baugh JA, Bucala R (2002) Macrophage migration inhibitory factor. Critical care medicine 30: S27&#x2013;S35.</Citation><ArticleIdList><ArticleId IdType="pubmed">11891404</ArticleId></ArticleIdList></Reference><Reference><Citation>Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nature reviews Immunology 3: 791&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097468</ArticleId><ArticleId IdType="pubmed">14502271</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng L, Metz CN, Fang Y, Xu J, Donnelly S, et al. (2003) MIF signal transduction initiated by binding to CD74. The Journal of experimental medicine 197: 1467&#x2013;1476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193907</ArticleId><ArticleId IdType="pubmed">12782713</ArticleId></ArticleIdList></Reference><Reference><Citation>Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, et al. (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nature medicine 6: 164&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">10655104</ArticleId></ArticleIdList></Reference><Reference><Citation>Calandra T, Froidevaux C, Martin C, Roger T (2003) Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis. The Journal of infectious diseases 187 Suppl 2S385&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">12792855</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong D, Macklon NS, Eijkemans MJ, Mannaerts BM, Coelingh Bennink HJ, et al. (2001) Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon). Fertility and sterility 75: 688&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">11287020</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira J (2000) Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. Journal of interferon &amp; cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20: 751&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="pubmed">11032394</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin MA, Haas CS, Zhu K, Mansfield PJ, Kim MJ, et al. (2006) Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood 107: 2252&#x2013;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1472703</ArticleId><ArticleId IdType="pubmed">16317091</ArticleId></ArticleIdList></Reference><Reference><Citation>Shyu LY, Yeh TM, Chang HH, Lin DP, Teng YH, et al. (2012) Macrophage migration inhibitory factor induces ICAM-1and thrombomobulin expression in vitro. Thrombosis research 129: 43&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">21890178</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi K, Otsuka K, Sato M, Takahashi R, Odai T, et al. (2012) Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity. Modern rheumatology/the Japan Rheumatism Association 22: 59&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">21607712</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X, Leng L, Wang T, Wang W, Du X, et al. (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25: 595&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3707630</ArticleId><ArticleId IdType="pubmed">17045821</ArticleId></ArticleIdList></Reference><Reference><Citation>Charrad RS, Gadhoum Z, Qi J, Glachant A, Allouche M, et al. (2002) Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 99: 290&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11756184</ArticleId></ArticleIdList></Reference><Reference><Citation>Assuncao-Miranda I, Amaral FA, Bozza FA, Fagundes CT, Sousa LP, et al. (2010) Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 24: 218&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">19776337</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Orgaization (1997) Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Second edition. Geneva: World Health Organization.</Citation></Reference><Reference><Citation>Ishii H, Majerus PW (1985) Thrombomodulin is present in human plasma and urine. The Journal of clinical investigation 76: 2178&#x2013;2181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC424339</ArticleId><ArticleId IdType="pubmed">3001144</ArticleId></ArticleIdList></Reference><Reference><Citation>Uehara S, Gotoh K, Handa H (2001) Separation and characterization of the molecular species of thrombomodulin in the plasma of diabetic patients. Thrombosis research 104: 325&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">11738074</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittman WA, Kumada T, Majerus PW (1989) Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin. Proceedings of the National Academy of Sciences of the United States of America 86: 7179&#x2013;7182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC298019</ArticleId><ArticleId IdType="pubmed">2550931</ArticleId></ArticleIdList></Reference><Reference><Citation>Calnek DS, Grinnell BW (1998) Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor. Experimental cell research 238: 294&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pubmed">9457083</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek AM, Jackman R, Rosenberg RD, Izumo S (1994) Endothelial expression of thrombomodulin is reversibly regulated by fluid shear stress. Circulation research 74: 852&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pubmed">8156632</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii H, Tezuka T, Ishikawa H, Takada K, Oida K, et al. (2003) Oxidized phospholipids in oxidized low-density lipoprotein down-regulate thrombomodulin transcription in vascular endothelial cells through a decrease in the binding of RARbeta-RXRalpha heterodimers and Sp1 and Sp3 to their binding sequences in the TM promoter. Blood 101: 4765&#x2013;4774.</Citation><ArticleIdList><ArticleId IdType="pubmed">12576329</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohji T, Urano H, Shirahata A, Yamagishi M, Higashi K, et al. (1995) Transforming growth factor beta 1 and beta 2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thrombosis and haemostasis 73: 812&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">7482408</ArticleId></ArticleIdList></Reference><Reference><Citation>Grey ST, Csizmadia V, Hancock WW (1998) Differential effect of tumor necrosis factor-alpha on thrombomodulin gene expression by human monocytoid (THP-1) cell versus endothelial cells. International journal of hematology 67: 53&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">9594445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HK, Kim JE, Chung J, Kim YT, Kang SH, et al. (2007) Lipopolysaccharide down-regulates the thrombomodulin expression of peripheral blood monocytes: effect of serum on thrombomodulin expression in the THP-1 monocytic cell line. Blood coagulation &amp; fibrinolysis : an international journal in haemostasis and thrombosis 18: 157&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">17287633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin SJ, Chen YH, Lin FY, Hsieh LY, Wang SH, et al. (2007) Pravastatin induces thrombomodulin expression in TNFalpha-treated human aortic endothelial cells by inhibiting Rac1 and Cdc42 translocation and activity. Journal of cellular biochemistry 101: 642&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pubmed">17211835</ArticleId></ArticleIdList></Reference><Reference><Citation>Masamura K, Oida K, Kanehara H, Suzuki J, Horie S, et al. (2003) Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family. Arteriosclerosis, thrombosis, and vascular biology 23: 512&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">12615662</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn RH, Deming CB, Johns DC, Champion HC, Bian C, et al. (2005) Regulation of endothelial thrombomodulin expression by inflammatory cytokines is mediated by activation of nuclear factor-kappa B. Blood. 105: 3910&#x2013;3917.</Citation><ArticleIdList><ArticleId IdType="pubmed">15677570</ArticleId></ArticleIdList></Reference><Reference><Citation>Nan B, Lin P, Lumsden AB, Yao Q, Chen C (2005) Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thrombosis research 115: 417&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">15733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LC, Shyu HW, Lin HM, Lei HY, Lin YS, et al. (2009) Dengue virus induces thrombomodulin expression in human endothelial cells and monocytes in vitro. The Journal of infection 58: 368&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">19307023</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LC, Yeh TM, Wu HN, Lin YY, Shyu HW (2008) Dengue virus infection induces passive release of high mobility group box 1 protein by epithelial cells. The Journal of infection 56: 143&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">18076993</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, et al. (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33: 14144&#x2013;14155.</Citation><ArticleIdList><ArticleId IdType="pubmed">7947826</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>